Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
doi: 10.1186/s40345-025-00397-4, 124
However, the compound is not included in IV therapy treatment directly
Exerkines in health, resilience and disease
Colleen McCabe, PharmD, BCOP, and Lindsay Mundy, PharmD, BCOP, led an engaging exploration of the benefits and potential pitfalls with the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in an oncology setting in their presentation, GLP-1s in Oncology: Miracle, Misdirection, or Missed Opportunity
US$ 24.06
US$ 22.77
US$ 27.34
US$ 20.06
US$ 26.40
